BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, Yonemori M, Yamada Y, Tatarano S, Nakagawa M, Enokida H. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. BMC Cancer 2021;21:48. [PMID: 33430801 DOI: 10.1186/s12885-020-07717-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin F, Han S, Yu W, Rao T, Ruan Y, Yuan R, Li H, Ning J, Xia Y, Xie J, Qi Y, Zhou X, Cheng F. microRNA‐486‐5p is implicated in the cisplatin‐induced apoptosis and acute inflammation response of renal tubular epithelial cells by targeting HAT1. J Biochem & Molecular Tox. [DOI: 10.1002/jbt.23039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tang M, Wang J, Fan L, Liu S. Comprehensive Analysis of Copy Number Variation, Nucleotide Mutation, and Transcription Level of PPAR Pathway-Related Genes in Endometrial Cancer. PPAR Research 2022;2022:1-17. [DOI: 10.1155/2022/5572258] [Reference Citation Analysis]
3 Ling Q, Wu S, Liao X, Liu C, Chen Y. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis. BMC Cancer 2022;22:765. [PMID: 35836137 DOI: 10.1186/s12885-022-09848-y] [Reference Citation Analysis]
4 Strømme O, Heck KA, Brede G, Lindholm HT, Otterlei M, Arum CJ. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors. Curr Issues Mol Biol 2021;43:286-300. [PMID: 34199766 DOI: 10.3390/cimb43010024] [Reference Citation Analysis]